News | June 29, 2009

Diagnostic Imaging Associated with Improved Health Outcomes, Little or No Impact on Cost

June 29, 2009 - The Medical Imaging & Technology Alliance (MITA) commended today the release of a new study demonstrating that use of imaging services in hospitals is associated with lower patient mortality, with little or no impact on length of stay and cost.

The study, led by David Lee, Ph.D., senior director, health economics and outcome research at GE Healthcare, was presented today at the 2009 Academy Health Annual Research Meeting in Chicago, providing further evidence on the value of medical imaging technology in improving health outcomes while minimizing cost of care.

“Not only does this study help strengthen what physicians, researchers and patients have known for decades regarding the value of medical imaging in improving the way numerous diseases and conditions are diagnosed and treated, it also provides notable findings on the cost effectiveness of these technologies,” said Ilyse Schuman, managing director of MITA, a member of the Access to Medical Imaging Coalition. “As policymakers and the health care community ardently work toward improving health care quality and accessibility, MITA encourages lawmakers to consider the role medical imaging can play in both improving outcomes and controlling costs.”

The study, based on the experience of more than 1 million patients in more than 100 U.S. hospitals, found that receiving a diagnostic imaging service – including computed tomography (CT), magnetic radiology (MR), ultrasound or X-ray – during a hospital admission may be associated with decreased inpatient mortality and with a statistically insignificant impact on admission-related costs. These findings contradict common assumptions about imaging’s role in driving health care costs.

“With comprehensive health care reform as a major focus this year, it is critical for policymakers, physicians and others to look to research when assessing the value of imaging in providing high quality and cost-effective care,” said Schuman. “We believe this study serves as a valuable springboard for new research questions and continued explorations into the value of medical imaging in saving lives and keeping down costs.”

The study included all clinical conditions treated in-hospital, assessing the experience of patients with private, commercial and governmental-sponsored insurance.

MITA hopes that this early study showcasing the positive relationship between imaging and decreased mortality will help advance future research and dialogue highlighting this important association.

For more information: www.medicalimaging.org


Related Content

News | Computed Tomography (CT)

July 16, 2024 — Arineta, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, proudly ...

Home July 16, 2024
Home
News | Computed Tomography (CT)

May 1, 2024 —In this 3-stage study, 3 cohorts were used for diagnostic performance, and prognostic performance ...

Home May 01, 2024
Home
News | Computed Tomography (CT)

April 22, 2024 — A new study showed that a non-invasive imaging test can help identify patients with coronary artery ...

Home April 22, 2024
Home
Feature | Computed Tomography (CT) | By Alberto Morales, MD

Cardiac CT scans, recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA) as ...

Home March 20, 2024
Home
News | Computed Tomography (CT)

February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Home February 20, 2024
Home
News | Computed Tomography (CT)

HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis to ...

Home January 15, 2024
Home
News | Computed Tomography (CT)

December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro ...

Home December 19, 2023
Home
Feature | Computed Tomography (CT) | By Andrew Michalski, PhD and Rohit Sood MD, PhD

Coronary artery disease (CAD), also known as ischemic heart disease, is the most common heart disease with a prevalence ...

Home December 05, 2023
Home
News | Computed Tomography (CT)

October 26, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care ...

Home October 26, 2023
Home
News | Computed Tomography (CT)

October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and ...

Home October 13, 2023
Home
Subscribe Now